BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 7119136)

  • 1. A dose-ranging study of lecithin in the treatment of primary degenerative dementia (Alzheimer disease).
    Brinkman SD; Pomara N; Goodnick PJ; Barnett N; Domino EF
    J Clin Psychopharmacol; 1982 Aug; 2(4):281-5. PubMed ID: 7119136
    [No Abstract]   [Full Text] [Related]  

  • 2. Failure of single-dose lecithin to alter aspects of central cholinergic activity in Alzheimer's disease.
    Pomara N; Domino EF; Yoon H; Brinkman S; Tamminga CA; Gershon S
    J Clin Psychiatry; 1983 Aug; 44(8):293-5. PubMed ID: 6874650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of physostigmine and lecithin on memory in Alzheimer disease.
    Peters BH; Levin HS
    Ann Neurol; 1979 Sep; 6(3):219-21. PubMed ID: 534419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No effect from double-blind trial of physostigmine and lecithin in Alzheimer disease.
    Wettstein A
    Ann Neurol; 1983 Feb; 13(2):210-2. PubMed ID: 6830183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral physostigmine and lecithin improve memory in Alzheimer disease.
    Thal LJ; Fuld PA; Masur DM; Sharpless NS
    Ann Neurol; 1983 May; 13(5):491-6. PubMed ID: 6347034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of lecithin on memory in patients with senile dementia of the Alzheimer's type [proceedings].
    Vroulis GA; Smith RC; Brinkman S; Schoolar J; Gordon J
    Psychopharmacol Bull; 1981 Jan; 17(1):127-8. PubMed ID: 7232644
    [No Abstract]   [Full Text] [Related]  

  • 7. Lithium-induced increases in red blood cell choline and memory performance in Alzheimer-type dementia.
    Brinkman SD; Pomara N; Barnett N; Block R; Domino EF; Gershon S
    Biol Psychiatry; 1984 Feb; 19(2):157-64. PubMed ID: 6424733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurochemical approaches to the treatment of senile dementia.
    Growdon JH; Corkin S
    Proc Annu Meet Am Psychopathol Assoc; 1980; 69():281-96. PubMed ID: 7413654
    [No Abstract]   [Full Text] [Related]  

  • 9. Memory enhancement with oral physostigmine in Alzheimer's disease.
    N Engl J Med; 1983 Mar; 308(12):720-1. PubMed ID: 6338388
    [No Abstract]   [Full Text] [Related]  

  • 10. Choline bitartrate treatment of Alzheimer-type dementias.
    Fovall P; Dysken MW; Lazarus LW; Davis JM; Kahn RL; Jope R; Finkel S; Rattan P
    Commun Psychopharmacol; 1980; 4(2):141-5. PubMed ID: 7428335
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of long-term high dose lecithin on erythrocyte choline transport in Alzheimer patients.
    Uney JB; Jones GM; Rebeiro A; Levy R
    Biol Psychiatry; 1992 Mar; 31(6):630-3. PubMed ID: 1581445
    [No Abstract]   [Full Text] [Related]  

  • 12. Double blind study of lecithin in patients with Alzheimer's disease.
    Fisman M; Merskey H; Helmes E; McCready J; Colhoun EH; Rylett BJ
    Can J Psychiatry; 1981 Oct; 26(6):426-8. PubMed ID: 7028239
    [No Abstract]   [Full Text] [Related]  

  • 13. Lecithin administration in Alzheimer dementia.
    Dysken MW; Fovall P; Harris CM; Davis JM; Noronha A
    Neurology; 1982 Oct; 32(10):1203-4. PubMed ID: 6889709
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of THA in treatment of Alzheimer-like dementia: pilot study in twelve patients.
    Summers WK; Viesselman JO; Marsh GM; Candelora K
    Biol Psychiatry; 1981 Feb; 16(2):145-53. PubMed ID: 7225483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lecithin in Alzheimer's disease.
    Etienne P; Gauthier S; Dastoor D; Collier B; Ratner J
    Lancet; 1978 Dec; 2(8101):1206. PubMed ID: 82173
    [No Abstract]   [Full Text] [Related]  

  • 16. A double-blind, placebo controlled trial of high-dose lecithin in Alzheimer's disease.
    Little A; Levy R; Chuaqui-Kidd P; Hand D
    J Neurol Neurosurg Psychiatry; 1985 Aug; 48(8):736-42. PubMed ID: 3897460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An analysis of dose-response of plasma choline to oral lecithin.
    Branconnier RJ; Dessain EC; Cole JO; McNiff-Langille ME
    Biol Psychiatry; 1984 May; 19(5):765-70. PubMed ID: 6733184
    [No Abstract]   [Full Text] [Related]  

  • 18. Fluctuations of free choline levels in plasma of Alzheimer patients receiving lecithin: preliminary observations.
    Chuaqui P; Levy R
    Br J Psychiatry; 1982 May; 140():464-9. PubMed ID: 7049290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alzheimer disease: lack of effect of lecithin treatment for 3 months.
    Etienne P; Dastoor D; Gauthier S; Ludwick R; Collier B
    Neurology; 1981 Dec; 31(12):1552-4. PubMed ID: 7198209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Choline in Alzheimer's disease.
    Renvoize EB; Jerram T
    N Engl J Med; 1979 Aug; 301(6):330. PubMed ID: 377082
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.